ArticlePharmaceutics2022

Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems.

Bárbara Pinto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.